
Adrenaline is the first-line emergency treatment for anaphylaxis. In the UK, it is available in different medication formats.
It acts quickly to reverse the most dangerous symptoms.

The most common adrenaline auto-injectors (AAIs) are EpiPen and Jext.

EURneffy is a new needle-free adrenaline nasal spray that has been approved in the UK for the emergency treatment of anaphylaxis.
It is now available for use in adults and children weighing 30kg or more, and may be prescribed as an alternative to an adrenaline auto-injector, following assessment by a healthcare professional.
Under Regulation 238 of the Human Medicines Regulations 2012, anyone can administer adrenaline in an emergency to save a life, even without formal medical training. This exemption helps ensure emergency treatment can be given quickly in a life-threatening situation